Koninklijke Philips Q4 2022 Earnings Report

Koninklijke Philips EPS Results

• Actual EPS: $0.42
• Consensus EPS: $0.06
• Beat/Miss: Beat by +$0.36
• One Year Ago EPS: N/A

Koninklijke Philips Revenue Results

• Actual Revenue: $5.54 billion
• Expected Revenue: $4.91 billion
• Beat/Miss: Beat by +$621.76 million
• YoY Revenue Growth: N/A

Koninklijke Philips Announcement Details

• Quarter: Q4 2022
• Date: 1/30/2023
• Time: N/A

Koninklijke Philips (NYSE:PHG) N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.